PhRMA pres warns against DTC moratorium

In a statement warning the Senate against imposing a moratorium on DTC, PhRMA president and CEO Billy Tauzin said: “DTC empowers patients by increasing their awareness of diseases and available treatments. Banning this information— even for just a couple of years—is not in the best interest of patients and physicians who every day make important healthcare decisions.”


Next Article in Pharmaceutical